financetom
Business
financetom
/
Business
/
Telesat Swings to Loss in Q4, Revenue Declines; Provides 2025 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Telesat Swings to Loss in Q4, Revenue Declines; Provides 2025 Guidance
Mar 27, 2025 5:36 AM

08:00 AM EDT, 03/27/2025 (MT Newswires) -- Telesat ( TSAT ) reported a Q4 net loss Thursday of CA$8.97 ($6.28) per diluted share, swinging from net income of CA$0.74 per diluted share a year earlier.

Analysts estimates were not available.

Revenue for the quarter ended Dec. 31 was CA$128 million, compared with CA$165.9 million a year earlier. One analyst surveyed by FactSet expected CA$120.6 million.

The satellite operator said it expects full-year 2025 adjusted earnings before interest, taxes, depreciation and amortization of CA$170 million to CA$190 million on revenue of CA$405 million to CA$425 million.

Analysts surveyed by FactSet expect 2025 revenue of CA$445.4 million.

Shares of Telesat ( TSAT ) were down 6.8% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sanofi Earns $5B Q3 Core Profit On Strong Dupixent And Vaccine Sales, Raises 2024 Forecast
Sanofi Earns $5B Q3 Core Profit On Strong Dupixent And Vaccine Sales, Raises 2024 Forecast
Oct 25, 2024
On Friday, Sanofi SA ( SNY ) reported a third-quarter business operating income of 4.61 billion euros ($4.99 billion), up 14.4% year-over-year and 19.9% in constant currency. The company reported third-quarter sales of 13.44 billion euros or $14.79 billion, beating the consensus of $13.97 billion. Sales increased 12.3% year over year and 15.7% on constant currency, led by solid growth from...
ANI Pharmaceuticals Launches Estradiol Gel Following US FDA's Final Approval for Abbreviated New Drug Application
ANI Pharmaceuticals Launches Estradiol Gel Following US FDA's Final Approval for Abbreviated New Drug Application
Oct 25, 2024
08:00 AM EDT, 10/25/2024 (MT Newswires) -- ANI Pharmaceuticals ( ANIP ) said Friday it has launched Estradiol Gel, a generic version of the EstroGel, after receiving the US Food and Drug Administration's final approval for its Abbreviated New Drug Application. The prescription medicine is meant to alleviate certain symptoms of menopause. Price: 61.69, Change: +2.41, Percent Change: +4.07 ...
--Provident Financial Keeps Dividend at $0.14 a Share, Payable Dec. 5 to Shareholders as of Nov. 14
--Provident Financial Keeps Dividend at $0.14 a Share, Payable Dec. 5 to Shareholders as of Nov. 14
Oct 25, 2024
05:31 AM EDT, 10/25/2024 (MT Newswires) -- Price: 15.31, Change: -0.28, Percent Change: -1.80 ...
Marubeni-backed salmon farm starts Japan sales as part of diversification push
Marubeni-backed salmon farm starts Japan sales as part of diversification push
Oct 25, 2024
TOKYO, Oct 25 (Reuters) - Marubeni ( MARUF ) on Friday began selling salmon from a farm operated near mount Fuji by its Norwegian partner, marking another step in Japanese commodity trading houses' expansion into the food business. Wild and sea-farmed salmon is one of the areas Marubeni ( MARUF ) and its rivals have been targeting- a growth market...
Copyright 2023-2026 - www.financetom.com All Rights Reserved